Remove connect collection all
article thumbnail

Embracing digitalization in the pharmaceutical supply chain

Pharmaceutical Technology

Digital transformation driven by machine connectivity. Fundamental to digitalization is the connection of automated machinery. From there, vast amounts of data can be collected, visualized and utilized to improve performance. “The big difference is that it is becoming more affordable and easier to take advantage of.

Engineer 286
article thumbnail

TK Elevator Rolls Out Cloud-Based Predictive Maintenance Solution

Pharmaceutical Technology

It collects data on components, systems, and performance to assist building owners and managers in increasing elevator and escalator uptime. It collects data from MAX-connected elevators all over the world, including door movements, trips, power-ups, car calls, and problem codes.

Big Data 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In Alzheimer’s Dementia, Should EEG Be Used as a Functional Biomarker of Target Engagement and Organizational Change When Evaluating Treatment Efficacy?

XTalks

RELATED ON-DEMAND XTALKS WEBINAR: Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies Register for this free webinar to learn about an AI-based, multi-domain digital biomarker platform designed to provide objective, diverse and home-based patient data collection in CNS clinical trials.

article thumbnail

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

Under the FDA’s drug safety Sentinel Initiative, the partnership will develop AI tools to collect key information from clinical notes within electronic health records (EHR). Together, Cerner Enviza and John Snow Labs have all the right expertise, data and technology to make it happen.”

article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

AI also helps in interactions with patients, as it can be used for automating patient recruitment and data collection. The result of all these improvements is better drug discovery, better-designed and safer clinical trials, and improved patient outcomes at lower costs than ever.

article thumbnail

SXSW 2024 Insights: Why the Greatest Risk a Brand Can Take Is Being Ordinary, Part 1

Intouch Solutions

Consequently, there’s a strong collective yearning for experiences that evoke the desire to savor and provoke wonder, discovery, and fascination, while feeling rooted in our shared humanity — offering safety and healing. The “ugly” aspects, the side effects, and the unpleasant truths are all concealed.

Branding 105
article thumbnail

A Reflection on Shared Moments of Strength and Progress in the Rare Disease Communities

Worldwide Clinical Trials

While each rare disease affects a small percentage of the population, collectively, there are many people living with rare diseases. We created the Rare Moments platform to have one place for all people invested in rare disease research, regardless of role, to engage and hear from others working towards common goals. What’s Next?